CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (11,881,137)	$ (13,066,661)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	490,641	442,262
Stock based compensation expense	4,022,283	2,033,341
Change in fair value of warrant liability	2,994,540	908,005
Loss on conversion of promissory notes	980,842
Common stock issued for consulting services	136,281	337,501
Bad debt expense	34,996	19,755
Change in operating assets and liabilities:
Accounts receivable	(4,635,445)	(181,935)
Prepaid expenses, other current assets and deposits	(78,587)	32,352
Inventory	30,000
Accounts payable and accrued liabilities	1,241,052	527,783
Deferred revenue	(301,312)	434,859
Net cash used in operating activities	(6,965,846)	(8,512,738)
Cash flows used in investing activities:
Purchase of assets under asset purchase agreement	(1,500,000)
Purchase of intangible assets	(286,953)
Purchase of property, plant and equipment	(351,615)	(229,591)
Net cash used in investing activities	(2,138,568)	(229,591)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	19,114,418	2,156,264
Proceeds from promissory notes, including $1,000,000 from a related party		1,800,000
Deferred offering costs		(181,104)
Purchase and cancellation of previously issued warrants	(4,090,952)
Net cash provided by financing activities	15,023,466	3,775,160
Net increase (decrease) in cash and cash equivalents	5,919,052	(4,967,169)
Cash and cash equivalents at beginning of year	1,393,132	6,360,301
Cash and cash equivalents at end of year	$ 7,312,184	$ 1,393,132
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing transactions:
Reclassification of warrants from liability to equity upon exercise of warrants		$ 2,455,042
Common stock and warrants issued upon conversion of promissory notes payable and accrued interest	$ 1,843,750
Property, plant and equipment acquired, and included in accounts payable	1,500
Intangible assets acquired, and included in accounts payable	11,845
Common stock issued for cashless exercise of options and warrants	4	$ 472
Reclassification of deferred offering costs to additional paid in capital	$ 181,104